Showing 20 of 104 recruiting trials for “sickle-cell-beta-thalassemia-disease”
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RecruitingNCT05153967 ↗
Cooperative Assessment of Late Effects for SCD Curative Therapies
👨⚕️ Michael R DeBaun, MD, MPH, Vanderbilt University Medical Center📍 5 sites📅 Started Jul 2022View details ↗
Cognitive Remediation Intervention to Prepare for Transition of Care
RecruitingNCT05170412 ↗
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
👨⚕️ Nicole M Farmer, M.D., National Institutes of Health Clinical Center (CC)📍 1 site📅 Started May 2022View details ↗
Cutaneous Hydration Assessment in SCD
RecruitingNCT06213402 ↗
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
👨⚕️ María del Mar Manú Pereira, PhD, Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH)📍 1 site📅 Started Nov 2021View details ↗
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
RecruitingNCT04416178 ↗
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
👨⚕️ Liza M. Johnson, MD, MPH, MSB, St. Jude Children's Research Hospital📍 1 site📅 Started Dec 2020View details ↗
Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
Enrolling by InvitationNCT04628585 ↗
Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
👨⚕️ Sherif M. Badawy, MD, MS, Ann & Robert H Lurie Children's Hospital of Chicago📍 1 site📅 Started Sep 2020View details ↗
High-flow Oxygen for Vaso-occlusive Pain Crisis
👨⚕️ Armand Mekontso, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Apr 2020View details ↗
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
👨⚕️ Robert Molokie, University of Illinois at Chicago College of Medicine📍 1 site📅 Started Jan 2020View details ↗
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
RecruitingNCT05376046 ↗
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
👨⚕️ Robert Nickel, MD, Children's National Research Institute📍 7 sites📅 Started Apr 2018View details ↗
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
👨⚕️ Michael Frett, MD, St. Jude Children's Research Hospital📍 2 sites📅 Started Feb 2018View details ↗
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
👨⚕️ Shalini Shenoy, MD, Washington University School of Medicine📍 4 sites📅 Started Mar 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →